EMD-72653
Cereblon with Golcadomide and Ikaros ZF1-2-3
EMD-72653
Single-particle3.26 Å
Deposition: 09/09/2025Map released: 15/10/2025
Last modified: 29/04/2026
Sample Organism:
Homo sapiens
Sample: Cereblon with Golcadomide with Ikaros ZF1-2-3
Fitted models: 9y7d
Deposition Authors: Watson ER
,
Lander GC
Sample: Cereblon with Golcadomide with Ikaros ZF1-2-3
Fitted models: 9y7d
Deposition Authors: Watson ER
,
Lander GC
Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma.
Mo Z ,
Groocock L ,
Wood S ,
Jankeel D ,
Mendy D ,
Watson ER ,
Kai Y ,
Deb G ,
Cote M ,
Janardhanan P ,
Fernandez-Deudero A ,
Barnes L ,
Peng S ,
Groza M ,
Kalashnikova E ,
Angelo M ,
Zhu J ,
Galasso R ,
Jang IS ,
Castillo MS ,
Fontanillo C ,
Polido G ,
Christoforou A ,
Kercher T ,
Lander GC ,
Wang K,
Narla RK ,
Carrancio S ,
Pierce DW ,
Rolfe M ,
Bence N ,
Lopez-Girona A
(2026) Blood Cancer Discov , 7 , 104 - 128
,
Groocock L ,
Wood S ,
Jankeel D ,
Mendy D ,
Watson ER ,
Kai Y ,
Deb G ,
Cote M ,
Janardhanan P ,
Fernandez-Deudero A ,
Barnes L ,
Peng S ,
Groza M ,
Kalashnikova E ,
Angelo M ,
Zhu J ,
Galasso R ,
Jang IS ,
Castillo MS ,
Fontanillo C ,
Polido G ,
Christoforou A ,
Kercher T ,
Lander GC ,
Wang K,
Narla RK ,
Carrancio S ,
Pierce DW ,
Rolfe M ,
Bence N ,
Lopez-Girona A
(2026) Blood Cancer Discov , 7 , 104 - 128
Grant Support:
- Other private: (United States)